Home LiteratureArticle Details
PMID: 2777915 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Characterization of the fission yeast cdc10+ protein that is required for commitment to the cell cycle.

Journal of cell science ·Vol. 92 ( Pt 1) ·1989-01-00 ·Pages 51-6

Simanis V, Nurse P

Abstract

We have used antiserum raised against a beta-galactosidase-cdc10+ fusion protein to identify the protein product of the cdc10+ start gene of Schizosaccharomyces pombe. This gene is required for progress through the G1 phase of the cell cycle and for activating processes such as the increase in histone mRNA level in preparation for S phase. The protein has an apparent molecular weight of 87,000 and is phosphorylated on multiple serine residues. The protein remains phosphorylated throughout the mitotic cell cycle and shows no significant steady-state changes in level. The antiserum has also detected a protein similar in size to p87cdc10 in human cells.

MeSH Terms
Antibodies, Fungal/isolation & purification Blotting, Western Cell Cycle Cell Cycle Proteins Fungal Proteins/analysis Genes, Fungal Interphase Mitosis Phosphorylation Saccharomycetales/genetics Schizosaccharomyces/genetics Schizosaccharomyces pombe Proteins Transcription Factors
Chemicals
Antibodies, Fungal Cell Cycle Proteins Fungal Proteins Schizosaccharomyces pombe Proteins Transcription Factors cdc10 protein, S pombe
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Simanis V
Imperial Cancer Research Fund, Cell Cycle Control Laboratory, London, UK.
Nurse P
Article Info
Journal
Journal of cell science
Abbr.
J Cell Sci
ISSN
0021-9533
Published
1989-01-00
Pages
51-6
Language
English
Region
England
NLM ID
0052457
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com